Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Eczema screening

Introduction

Overview

Overview

Hanifin and Rajka criteria are the gold standard for diagnosing eczema. [1] [2]

Eczema screening

Eczema screening

 Table 1. Hanifin and Rajka Criteria “www.med.or.jp” (PDF).
Major Criteria Minor Criteria
Pruritus Xerosis
Typical morphology and distribution, flexural lichenification in adults, facial and extensor eruptions in infants and children Ichthyosis / palmar hyper-linearity, keratosis pilaris
Chronic or chronically relapsing dermatitis Immediate (type 1) skin-test reactivity
Personal or family history of atopy (asthma, allergic rhinitis, atopic dermatitis) Raised serum IgE
Early age of onset
Tendency toward cutaneous infections (especially Staphylococcus aureus and herpes simplex virus), impaired cell-mediated immunity
Tendency toward non-specific hand or foot dermatitis.
Nipple eczema
Cheilitis
Recurrent conjunctivitis
Dennie-Morgan infraorbital fold
Keratoconus
Anterior subcapsular cataracts
Orbital darkening
Facial pallor, facial erythema
Pityriasis alba
Anterior neck folds
Itch when sweating.
Intolerance to wool and lipid solvents.
Perifollicular accentuation
Food intolerance
Course influenced by environmental or emotional factors
White dermographism, delayed blanch.
References

References

  1. ↑ Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL; et al. (2014). “Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis”. J Am Acad Dermatol. 70 (2): 338–51. doi:10.1016/j.jaad.2013.10.010. PMC 4410183. PMID 24290431.
  2. ↑ Schulte-Herbrüggen O, Fölster-Holst R, von Elstermann M, Augustin M, Hellweg R (2007). “Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis”. Int Arch Allergy Immunol. 144 (3): 211–6. doi:10.1159/000103994. PMID 17579279.
  3. ↑ Avena-Woods C (2017). “Overview of atopic dermatitis”. Am J Manag Care. 23 (8 Suppl): S115–S123. PMID 28978208.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.